RxDoctor Payments Data

David Kirsch

Radiation Oncology · Durham, NCNPI 1932181039

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,304 of the $1,397 with a category attached, or 93.4%. Boehringer Ingelheim accounts for 93.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,304 and has fallen 96.8% since, to $41 in 2023.

$1,397in general payments, 2019–2025

Across 4 payments — averaging $349.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$1K
  • Siemens Medical Solutions USA, Inc.$51
  • Trisalus Life Sciences, Inc.$41
$6,169,039in research payments, 2019–2025

Across 51 payments — averaging $120,962 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$6.1M
  • Siemens Medical Solutions USA, Inc.$50K
  • Varian Medical Systems, Inc.$25K
  • Amgen$15K

What the payments were for

  • Travel & lodging$1,30493%
  • Food & beverage$937%

General payments by program year

19
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,397 in reported general payments places this provider in the 70th percentile of 199 radiation oncology providers in North Carolina.

See all radiation oncology providers in North Carolina →

Other radiation oncology in Durham

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →